Cholesterol, Serum/Plasma
Cholesterol is a steroid and waxy substance that is found in the blood, tissues, and organs of all mammals including humans. Most of the cholesterol present in the blood is synthesized mainly in the liver; endogenously synthesized cholesterol accounts for 75% of the cholesterol level, and diet accounts for the other 25%. Total cholesterol level in the body is dependent on many factors such as diet, liver function, lipid metabolism, heredity, and lifestyle choices. Testing serum cholesterol is the first step in screening for atherosclerosis risk. Atherosclerosis is hardening or blocking of the arteries of the heart and peripheral tissues due to the build-up of cholesterol and degradation products. If an increase in serum cholesterol is found, an extended lipid profile may be requested, which includes triglycerides, high density lipoprotein (HDL), and low density lipoprotein (LDL). Increased cholesterol is common and can be seen in increased cholesterol ingestion, hereditary hyperlipoproteinemia, liver disease, Cushing’s disease, hypothyroidism, and other metabolic disorders. Long-term increased cholesterol may lead to atherosclerosis and heart disease. Increased cholesterol per se has no symptoms, making it very important to have levels checked regularly. Various medications are available to decrease the lipid levels in the blood. A decrease in cholesterol can be seen in malabsorption, hyperparathyroidism, burns, chronic illness, liver disease, and malnutrition. Although the risks of increased cholesterol are well known, low cholesterol levels have been linked to depression, anxiety, and stroke.
- Diagnosis of familial hypercholesterolemia
- As an aid in diagnosis of cardiovascular disorders such as atherosclerosis
- As an aid in evaluation of cardiac risk profile
- As an aid in diagnosis of hypertension
- As an aid in diagnosis of diabetes mellitus, nephrotic syndrome, and liver disease with biliary obstruction.
Increased in:
- Familial hypercholesterolemia
- Familial combined hyperlipidemia
- Hypothyroidism
- Uncontrolled diabetes mellitus
- Nephrotic syndrome
- Liver disorders such as biliary obstruction and hepatocellular carcinoma
- Cushing’s syndrome
- Acute intermittent porphyria
- Use of corticosteroids
Decreased in:
- Severe liver disease (acute hepatitis, cirrhosis, malignancy)
- Hyperthyroidism
- Severe acute or chronic illness
- Malnutrition and malabsorption
- Extensive burns
- Gaucher’s disease
- Tangier disease
- Abetalipoproteinemia
Adults
Desirable: <200 mg/dL (<5.18 mmol/L)
Borderlie High: 200-239 mg/dL (5.18-6.19 mmol/L)
High: >=240mg/dL (>=6.22 mmol/L)
Children
Desirable: <170 mg/dL (<4.40 mmol/L)
Borderlie High: 170-200 mg/dL (4.40-5.18 mmol/L)
High: >=200mg/dL (>=5.18mmol/L)
Enzymatic, colorimetric method.
Serum (SST) or Plasma Heparin (Green).
Stability
- Ambient: 3-5 days
- Refrigerated: 7 days
- Frozen: 90 days
1-3 days.
- JAMA. 2001;285:2486. [PMID: 11368702]
- Mayo Clinic Proc. 2006;81:1225. [PMID: 16970219]
- Med Gen Med. 2006;8:54. [PMID: 16915184]
- Curr Atheroscler Rep. 2001 Sep;3(5):404-11. [PMID: 11565569]
- Clin Chem Lab Med. 2000 Apr;38(4):287-300. [PMID: 10928647]
- Am J Med Sci. 2005;330:295. [PMID: 16355014]
- Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).
- Jacobs DS, DeMott WR, Oxley DK. Laboratory Test Handbook, fifth edition, Lexi-COMP, Inc (2004). Pp. 146-147and 212-213.
- Pagana K, Pagana T. Mosby's Manual of Diagnostic and Laboratory Tests. 3rd Edition, St. Louis: Mosby Elsevier (2006). Pp. 351-356